SPAG5 and breast cancer: These results, together with the downregulation of SPAG5 and cyclin-B1, and upregulation of CDK inhibitor p21 proteins, suggest that depletion of c-MYC reduced SPAG5 expression and consequently BC cell proliferation (Fig. 3C, F, I).